The state of Massachusetts is suing opioid maker Purdue Pharma and, for the first time, members of the Sackler family that owns the company, claiming that the drug maker violated the state's consumer protection law by continuing to assure doctors that its flagship product OxyContin (oxycodone) ...
Washington —The Supreme Court on Monday grappled with whether to uphold abankruptcy plan for Purdue Pharmaover objections from the Biden administration about the broad legal protections it grants the Sackler family from civil lawsuits related to their role in the opioid epidemic. At the heart of ...
In late June, the US Supreme Court handed down its long-awaited opinion reviewing Purdue Pharma’s $6 billion settlement in the national opioid litigation in Harrington v Purdue Pharma.1 The settlement had been challenged because it included a bankruptcy deal that allowed Purdue’s fam...
specifically, the decision to release the Sacklers from civil liability for the opioid epidemic. The matter is under review by the Supreme Court, which held oral arguments in the case, known as Harrington v. Purdue Pharma L.P., on Monday morning. ...
Purdue Pharma could be heading for bankruptcy but the extent to which it would affect the Sackler family fortunes remains unclear.
Flying under the chaos of the Covid-19 pandemic, one of America’s richest families, the billionaire Sackler family who fully own Purdue Pharma and put themselves forward as the epitome of good works funded by the fruits of the capitalist system, are being held to account for allegedly earnin...
The legal pressure on the prominent family behind the company that makes OxyContin, the prescription painkiller that helped fuel the nation's opioid epidemic, is likely to get more intense.
The Met, which overlooks Central Park and houses some of the most famous and precious artworks and antiquities in existence, said it had reached an agreement with the descendants of two of the Sackler brothers behind OxyContin that seven named exhibition spaces at the institution would no longer...
Giuliani Partners also became involved in the pharmaceutical industry, with Purdue Pharma, a company that paid $2 million in DEA fines for misleading the public around opioid addictions, serving as a major client. In 2008, he ran for the Republican presidential nomination and became an early ...
Back alley drug dealers go to jail when they get caught. Corporate boardroom drug dealers can hide behind bankruptcy and keep most of their billions when they get in trouble. That’s the annoying takeaway from anewly approved bankruptcy settlementthat will let the most notorious drug pushers in...